Harvard Bioscience (Harvard Bioscience) Order Backlog for Technology (USD Mil) : 7.50 (As of Sep. 2016)

View and export this data going back to 2000. Start your Free Trial

What is Harvard Bioscience Order Backlog for Technology (USD Mil)?

Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet.

Harvard Bioscience's Order Backlog for Technology (USD Mil) for the quarter that ended in Sep. 2016 was 7.50 , which higher from pervious quarter (Jun. 2016)'s result by 15.38%.

The historical rank and industry rank for Harvard Bioscience's Order Backlog for Technology (USD Mil) or its related term are showing as below:

HBIO's Order Backlog for Technology (USD Mil) is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Order Backlog for Technology (USD Mil) only.

Harvard Bioscience Order Backlog for Technology (USD Mil) Historical Data

The historical data trend for Harvard Bioscience's Order Backlog for Technology (USD Mil) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Order Backlog for Technology (USD Mil) Chart

Harvard BioscienceQuarterly Data

Trend

Jun16

Sep16

Order Backlog for Technology (USD Mil)

Get a 7-Day Free Trial

Bookings (USD Mil)

Get a 7-Day Free Trial

Competitive Comparison of Harvard Bioscience's Order Backlog for Technology (USD Mil)

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Order Backlog for Technology (USD Mil), along with its competitors' market caps and Order Backlog for Technology (USD Mil) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Bioscience (NAS:HBIO) Order Backlog for Technology (USD Mil) Explanation

The term backlog refers to a buildup of work that has not yet been completed by the company. The presence of a backlog can have positive or negative implications. For example, a rising backlog of product orders might indicate rising sales. On the other hand, companies generally want to avoid having a backlog as it could cause (or be a result of) increasing inefficiency in the production process. Likewise, a falling backlog might be a sign of lagging demand but could also be a result of improving production efficiency. Naturally, unexpected backlogs can compromise forecasts and production schedules.

Harvard Bioscience Order Backlog for Technology (USD Mil) Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Order Backlog for Technology (USD Mil) provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (Harvard Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (NAS:HBIO) » Definitions » Order Backlog for Technology (USD Mil)

Comparable Companies

Traded in Other Exchanges

HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Executives

James W Green	director, officer: Chief Executive Officer	12525 CHADRON AVENUE, HAWTHORNE CA 90250
Alan I Edrick	director	20200 SUNBURST STREET, CHATSWORTH CA 91311
Jennifer Cote	officer: Interim CFO	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Bertrand Loy	director	C/O ENTEGRIS, INC., 129 CONCORD RD, BILLERICA MA 01821
Thomas W Loewald	director	81 WYMAN STREET, WALTHAM MA 02451
John F Kennedy	director	C/O NET PERCEPTIONS INC, 7700 FRANCE AVE. SOUTH, EDINA MN 55435
Katherine A. Eade	director	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Susan M. Steele	director	C/O HILL INTERNATIONAL, INC., 2005 MARKET ST., 17TH FLOOR, PHILADELPHIA PA 19103
Kenneth Fletcher Olson	officer: Chief Operating Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Michael A. Rossi	officer: Chief Financial Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Yash Singh	officer: Executive Vice President	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Jeffrey Duchemin	officer: Chief Executive Officer	14 EASTLAND TERRACE, HAVERHILL MA 01830
Kamalam Unninayar	officer: Chief Financial Officer	C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
Robert E. Gagnon	officer: Chief Financial Officer	C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
George Uveges	director	C/O MFIC CORPORATION, 30 OSSIPEE ROAD, NEWTON MA 02464